Pharma Produkt

Zusammensetzung information

Zusammensetzung, Synonyme

  • Immunoglobulin, anti-(human B-lymphocyte antigen CD19 (Leu-12)) mouse monoclonal scFv fragment {IGKV-IGKJ-tetraglycyl-L-seryltetraglycyl-L-seryltetraglycyl-L-seryl-IGHV-IGHJ} fusion protein with tetraglycyl-L-serine fusion protein with immunoglobulin, anti-(human T-cell surface glycoprotein CD3ε chain (Leu-4)) mouse monoclonal scFv fragment {IGHV-IGHJ-L-valyl-L-glutamyltetrakis[diglycyl-L-seryl]diglycyl-L-valyl-L-aspartyl-IGKV-IGKJ} fusion protein with hexa-L-histamine
  • MEDI-538 (Medimmune, USA)
  • MT-103
  • Blinatumomabum
  • Immunoglobulin scFv-scFv, anti-[Homo sapiens CD19 (B lymphocyte surface antigen B4, Leu-12)]/anti-[Homo sapiens CD3 epsilon (CD3E, Leu-4)] Mus musculus monoclonal antibody bispecific single chain; Mus musculus scFv anti-CD19 [V-KAPPA (IGKV3-4-IGKJ1*01) [10.3.9] (1-111)-tris(tetraglycyl-seryl)-VH (IGHV1-54-(IGHD)-IGHJ4*01, S123>T) [8.8.17] (127-250)]-tetraglycyl-seryl-Mus musculus scFv anti-CD3E [VH (IGHV1-4-(IGHD)-IGHJ2*01) [8.8.12] (256-374)-valyl-glutamyl-tetrakis(diglycyl-seryl)-diglycyl-valy
  • Blinatumomab

Andere Arzneimittel

  Bezeichnung PZN Form Verpackung Hersteller Preis
Details BLINCYTO 38,5 µg Plv.f.e.Konz.u.Lsg.z.H.e.Inf.Lsg. P11182837 PLK 1 St AMGEN € 2615.04